Prohost Biotech – Exclusive Biotech Research

Exclusive Market Insight

& Scientific analysis

  • Exclusive Posts
  • Industry Newsletters
  • Clinical Trials
  • Possible Takeovers
  • Technology of the Week
  • Stock Table
  • Therapeutic Vaccines
  • Development-Stage Firms
  • Genomics
  • Prohost Picks
  • And much more...
Menu
  • Impacting News
  • News & Comments
  • Today’s Highlights
  • Trick or Trade
  • Prohost Letters
  • Login / Register
    • Login
    • Register
  • Contact Us
  • Impacting News
  • News & Comments
  • Today’s Highlights
  • Trick or Trade
  • Prohost Letters
  • Login / Register
    • Login
    • Register
  • Contact Us

Latest Articlesddd

GSK Announces the Linked by Lupus: Optimal Care Initiative to Help Support Individuals with Lupus in the US

July 28, 2025 0
GSK in the NEWS Today, GSK plc (GSK) announced the launch of the Linked by Lupus: …

Eli Lilly Completes Acquisition of Verve Therapeutics to Advance One-Time Treatments for People with High Cardiovascular Risk

July 25, 2025 0
Eli Lilly Acquired Verve Therapeutics Eli Lilly and Company (LLY) today announced the successful completion of …

AstraZeneca’s Product Gefurulimab Demonstrated Daily Living of Adults with Generalised Myasthenia Gravis in PREVAIL Phase III Trial

July 24, 2025 0
AstraZeneca's Product Gefurulimab Once-weekly self-administered subcutaneous C5 inhibitor showed statistically significant and clinically meaningful reduction in …

AstraZeneca Plans to Invest $50 billion in America for Medicines Manufacturing and R&D Generated in the US  

July 22, 2025 0
AstraZeneca in the NEWS Cornerstone of investment is a proposed new multi-billion dollar drug substance manufacturing …

 Axsome Therapeutics Hosts Frontiers in Brain Health R&D Day Reviewing Industry-Leading Late-Stage CNS Pipeline

July 21, 2025 0
Axsome Therapeutics Axsome Therapeutics (AXSM) is a biopharmaceutical company leading a new era in the treatment …

Today About: Alnylam Pharmaceuticals, Bristol-Myers Squibb and Intellia Therapeutics

July 18, 2025 0
Friday, August 18, 2025 Solid Earning, revenue growth, President Trump signing crypto bills, and Crispr Therapeutics …

Question & Answer About Kiniksa Pharmaceuticals

July 17, 2025 0
Q & A: Kiniksa Pharmaceuticals Q: Do you have any recent news from Kiniksa Pharmaceuticals?  A: …

About Making Sense, Date of Moderna’s Q2nd Financial Results and AbbVie’s Agreement  

July 16, 2025 0
The root-cause of the stock market’s volatility and inflation does not make sense as we are …

Vertex Announces European Commission Approval of ALYFTREK®- a New Once-Daily CFTR Modulator for the Treatment of Cystic Fibrosis

July 2, 2025 0
Vertex Pharmaceuticals in the NEWS On Jul. 1, 2025, Vertex Pharmaceuticals (VRTX) announced that the European …

Why BioNTech Acquiring CureVac Is Good News For BioNTech

June 30, 2025 0
BioNTech Announces Strategic Transaction to Acquire CureVac in Public Exchange Offer We wanted to know the …

Vertex Pharmaceuticals Presents Positive Data for Zimislecel in Type1 Diabetes at the American Diabetes Association 85th Scientific Sessions

June 26, 2025 0
Vertex Pharmaceuticals Simultaneous Announcements Vertex Pharmaceuticals (VRTX) announced simultaneous presentation and publication of updated data from …

Cidara Therapeutics Announces Positive Topline Results From Phase 2b Navigate Trial evaluating  CD388 – A Nonvaccine Preventative of Seasonal Influenza

June 24, 2025 0
Cidara Therapeutics Cidara Therapeutics uses its proprietary Cloudbreak® platform to develop novel drug-Fc conjugates (DFCs) comprising …

Exelixis Announces Zanzalintinib in Combination with an Immune Checkpoint Inhibitor Improved Overall Survival in Patients with Metastatic Colorectal Cancer

June 23, 2025 0
Exelixis in the NEWS Exelixis (EXEL) announced positive topline results from the STELLAR-303 phase 3 pivotal …

Why We Believe That BioNTech Will Have A Great Future

June 18, 2025 0
Biotechnology and biopharmaceutical firms were doing great until the day the COVID-19 pandemic changed the lives …

Alnylam Pharmaceuticals Receives EC Approval for AMVUTTRA® for the Treatment of ATTR Amyloidosis with Cardiomyopathy

June 9, 2025 0
Alnylam Pharmaceutical's News Today is Great Before we get to the press release from Alnylam Pharmaceuticals …

Why Prohost Decided To Pick Soleno Therapeutics For Investment

June 5, 2025 0
Soleno Therapeutics Soleno Therapeutics (SLNO) announced that’s Marketing Authorization Application (MAA) seeking regulatory approval of Diazoxide …

Important News For Vera Therapeutics

June 2, 2025 0
Vera Therapeutics As expected, Vera Therapeutics (VERA) product Ataticept achieved proteinuria reduction in ORIGIN Phase 3 …

Why Many Biotech Investors Believe Akero Therapeutics Will Soon Be Acquired By A Top-Tier Company

May 23, 2025 0
Akero Therapeutics Akero Therapeutics (AKRO) - a clinical-stage company developing transformational treatments for patients with serious …

Answering Questions About Vera Therapeutics

May 19, 2025 0
Vera Therapeutics Q: What did Vera Therapeutics announce on May 6th that is more than what …

Exelixis First Quarter 2025 Financial Results Plus Corporate Update

May 15, 2025 0
Exelixis in the NEWS   Two days ago, Exelixis (EXEL) reported financial results for the first quarter …

Posts pagination

Previous 1 2 3 4 5 … 78 Next

Search ProhostBiotech

Popular Links

Aerie Pharmaceuticals (AERI) Agenus (AGEN) Alnylam Pharmaceuticals (ALNY) Amgen (AMGN) Array BioPharma (ARRY) AstraZeneca Plc (AZN) Bellicum Pharmaceuticals Inc (BLCM) Bristol-Myers Squibb (BMY) Celgene (CELG) Celldex Therapeutics (CLDX) Cellectis (CLLS) Celyad (CYAD) Compugen (CGEN) CRISPR Therapeutics (CRSP) CytomX Therapeutics Inc (CTMX) Editas Medicine Inc (EDIT) Enanta Pharmaceuticals (ENTA) Exelixis (EXEL) Gilead Sciences (GILD) Halozyme Therapeutics (HALO) Illumina (ILMN) ImmunoGen (IMGN) Incyte (INCY) Innoviva (INVA) Intellia Therapeutics (NTLA) Ionis Pharmaceuticals Inc (IONS) Karyopharm Therapeutics Inc (KPTI) Merck (MRK) Moderna Inc (MRNA) Nektar Therapeutics (NKTR) Neurocrine Biosciences (NBIX) Novartis (NVS) Portola Pharmaceuticals Inc (PTLA) PTC Therapeutics (PTCT) Regeneron Pharmaceuticals (REGN) Regenxbio (RGNX) Rhythm Pharmaceuticals Inc (RYTM) Sangamo Therapeutics Inc (SGMO) Sarepta Therapeutics (SRPT) Seagen Inc (SGEN) Spark Therapeutics Theravance Biopharma (TBPH) Vertex Pharmaceuticals (VRTX) Xoma (XOMA)
  • Recent

ProhostBiotech Archive

Sign Up for Weekly Emails

Prohost Biotech – Exclusive Biotech Research Copyright © 2025.
© 2014 Prohost Biotech. All rights reserved.

Privacy Policy | Cancellation Policy | Forward Looking Statement

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.